*** Disclaimer: This Database is still undergoing update on daily basis to prevent errors, discrepancies, and missing records. Please Contact FDIC@nafdac.gov.ng for enquires ***

Product Details

Braftovi 50mg Capsules

Encorafenib
50 mg
Capsule

ROA

Oral

Applicant Name

Pfizer Specialties Limited

NRN

A4-100330

Status

Active


ATC Code

L01EC03  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

 

Product Description

Braftovi 50mg Capsules A4-100330 Braftovi 50mg Capsules Each hard capsule contains 50 mg of encorafenib. List of excipients Capsule content Copovidone (E1208) Poloxamer 188 Cellulose microcrystalline (E460i) Succinic acid (E363) Crospovidone (E1202) Silica colloidal anhydrous (E551) Magnesium stearate (E470b) Capsule shell Gelatin (E441) Titanium dioxide (E171) Iron oxide red (E172) Iron oxide yellow (E172) Iron oxide black (E172) Capsule POM PFIZER SPECIALITIES LTD., LUGARD AVENUE, 7TH FLOOR OFF ALFRED RAWANE ROAD, (KINGSWAY ROAD) IKOYI LAGOS LAGOS Nigeria Catalent Pharma Solutions LLC, 14 Schoolhouse Road - Somerset, NJ 08873, US, United States 26/01/2023 25/01/2028

Manufacturer Name

Catalent Pharma Solutions LLC

Manufacturer Country

UNITED STATES OF AMERICA  

Approval Date

2023-01-26  

Expiry Date

2028-01-25